Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Short covering should last throughout the day and tomorrow imo. Volume is still extremely low compared to past trading days. Covering may take a while, or they may wait until it drops back down. Interesting how an investigation was done and yet this is still trading.
The volume today is short covering and bounce players. All a one day thing.
Don't get marriage minded. It's just a quickie.
And what ever you do, don't put pictures of you and her on Facebook. Those will come back to haunt you one day.
The people that knew this was a scam shorted it, and when a short sells his shares it is shown as a buy, and makes stock prices go up. You will see this at .0001 in a few weeks.
seems steady at 13 cents. It was at a penny earlier but they wouldnt fill me. 13 cents seems way too high
why would the this stock be up today? i was thinking it was going to go all the way down below a penny.
It is on the Greys and likely will never have a bid ask unless a MM does that 15-c211 thingy which means a MM gott vouch for the company
OUT .12 cut my lost. Thanks god
why is there no bid and ask?
Can't get filled here. Worth a gamble.
price is really jumping around. And i still dont see a bid or and ask!
Grey is the new hot color this fall. All real stocks want to be grey.
Trading at a penny
People has wreck the Value!! Ill come back but it will take a while ! LOOSE 95% HERE THIS MORNING!! Bull S........
Financials out on 10/2/09. If it's a SCAM, Why is the SEC allowing to post financials? LMFAO
http://finance.yahoo.com/q/is?s=gvbp.ob
Have fun thinking of a GOOD comeback!!
Regards,
Knight_78
they almost always trade under same symbol - no E or Q . Just you will not see an bid or ask and expect trades to be unorderly - IE they will trade all over the place
do u know what symbol will be? How do u know it trade tomorrow? thanks
halt will be over at midnight could trade tomorrow i
dump as soon as they begin trading again, I called this to hit zero long ago.
This was not put out to the public properly. They really never had a deal they were just pushing news. This will open under 1 cent.
They are suspended through midnight on the 6th, so they can begin trading again when the market opens on the 7th
So stock resumes trading on Oct 7? or oct 6? what times? thanks
I call my broker and told them about stock trade on GRAY market. THey told me they never heard of it before! Only pink and over the counter market only! Never ever heard GRAY MARKET trading! I am very confused on these issue on Oct 7!!!
Someone said it is supposed to hit the grays on 10-6. I guess we will see.
Restarts 10/07
Genova Biotherapeutics Inc.; Order of Suspension of Trading
Friday 09/25/2009 10:33 PM ET - Find Government Press Releases
Related Companies
Symbol Last %Chg
GVBP 0.20 0.00%
As of 12:00 AM ET 9/22/09
September 23, 2009.
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Genova Biotherapeutics Inc. ("Genova").
Genova is incorporated under the laws of Nevada and has its primary headquarters in New York, New York. Questions have arisen regarding stock promotional activity for Genova and the adequacy and accuracy of press releases, financial statements, and statements on the company's Web site concerning the company's current financial condition, business and operations, and stock promoting activity.
The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in Genova's securities.
Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST, on September 23, 2009 through 11:59 p.m. EST, on October 6, 2009.
By the Commission.
Florence E. Harmon,
Deputy Secretary.
Citation: "74 FR 49048"
Document Number: "File No. 500-1"
Federal Register Page Number: "49048"
"Notices"
Do u have any idea WHEN this be resume trading?? thanks
I wish we did as well...then bring on the free market...
I'd love to see them bring Chinese justice to American stock
fraud such as this. for this guy and for sponge's M&M and whoever
was a key player. boo yah boo yah
instead its a f'n game.
thats right... this Company goes up 10 times it value in 7 days... but no body made money,
it bounces from a technical low of .23 back to .36 a 50% rally but no body made money...
now your trying to tell everyone how to invest
you just basically told everyone you have no clue how to invest or trade stocks.. not only did you watch one of the best stock runs of the year...
but you were soooo sure about your convictions... on how much of a scam this company was
when this stock hit 1.00 and someone wrote that the margin would be 3.50 for every one dollar they wanted to short.... you typed... you typed!!!!
instead of shorting this stock...
which fits in with the fact the only reason your probably here is because you took a loss on this stock or a some how affiliated stock way back when....
and since.. you never make mistakes, instead of blaming yourself, you blame the stock...
if im wrong...
please dont tell us you have never invested or traded...in any of these stocks... like GVBP
because to spend countless hours upon hours of typing up your essay of messages on these stocks you have never invested or traded....
is just really really sad...
like they say 'Those Who Can’t Do, Teach...
in your case... the 3:00 bell went 2 hours ago... no one is sitting at their desk....
I think the Chinese use capital punishment in stock fraud cases.
But this company never was Chinese.
Posted by: Potse
Date: Thursday, September 10, 2009 3:24:32 AM
In reply to: LONGBEACHBOY who wrote msg# 64
LONGBEACHBOY...GVBP/KHGT relationship.....
"Is KHGT.PK what Genova bought out?"
The intellectual property that GVBP currently owns was previously the property of NextGen Bioscience (NXGB, now trading as KHGT). For various reasons NXGB's attempt to develop a pharm/biotech business (identical to GVBP's business plan) failed. Some of the reasons for this failure were out of control of the company, but most of them were self-inflicted.
NXGB was probably the most puzzling/frustrating investment I have ever made. Opportunities to develop a viable development-stage pharma/biotech were pretty much squandered by questionable decision-making from the get-go. I have followed GVBP since the pharma IP was purchased earlier this year. To a large extent GVBP is basically duplicating the same mistakes that eventually led to the downfall of NXGB (for example, the needless forward split before the company has raised any financing).
Despite the collapse in share price, I have maintained my position in KHGT (Kalahari Greentech, formerly NXGB). A pretty large, well-known, well-respected European institutional investor held a significant ownership position in NXGB at the time its pharma business model was implemented. The relative lack of volume that NXGB experienced makes me believe that investor still has a large position. Ironically, I am kind of guessing that whoever is now pulling the strings at KHGT (contact was changed to a China address) will probably do a forward split at some point. Perhaps that coupled with some promotion will allow for a decent tradeable move in the stock.....
http://www.kalaharigreentech.com/default.asp
They should have capital punishment for those responsible for foisitng such misery on so many-they sure did make my capital get punished. ouch!! lol. No, seriously, they should go away for life just like Madoff got at least, solitary confinement at best for them or to a North Korean hard labor place. right crazybetting? Then, we'd see this s!!t subside in a big way. JMO.
Agree....the Greys is not a good thing.
No ... this will trade on the Greys when the suspension is over.
Some brokerages will not let investors buy on the greys.
Stock price will most likely tumble.
jmo
I feel for the folks that lost here.I pray the day comes when this stuff will not be premitted at all.
"So this stock will trade as normal on Oct 7." No, it will trade unsolicited, with no bids or offers visible, in a workout market (known as the grey market or grey sheets).
"We will see pps down but not as bad as some guy talk." "Some guy" probably knows exactly what he's talking about. The price cannot be predicted, but it won't be good. Ignore whoever told you "not as bad as some guy talk".
"...i assume pps will be ok." It will be far from "ok"; typically, there may be a few decent trades for a day or two--or there may not--and then it will plummet. Remember, there is nothing to this company. It has no intrinsic value, and most people are now aware of that because of the suspension.
"I feel a bite better after i read this information from stockwatch." If so, you have either misread the information, or it was intentionally misleading. There is nothing to feel very good about here. The only thing left to do is to figure out an exit strategy. Strange as it may seem, there may still be a few carrion feeders who hang around and tell you otherwise, strictly for their own purposes. Don't listen to anyone who paints less than a dismal picture of a suspended bulletin board stock.
Once more, although I have removed this message board from my list, and pretty much erased you from my memory, Harry:
"BUDDY STOP sending me messages." I'm still not your buddy, although you now seem to think your schoolyard behavior of repeating that term over and over marks you as very clever. I don't "buddy up" with those who designate themselves "gods", especially when they pair that designation with juvenile behavior.
"dont you get it" Yes, I get all of it. I have pointed out some of the many things you don't get. Try to learn from that.
"...talking about how no one should invest in it...." Of course no one should have invested in it. It was a scam, which is one of the many things you just don't get, or from which you would like to distract everyone else (which is far more important from your Harry Lime point of view). And please quit implying you made a killing on it. You didn't, and we both know it. Anyone as sore as you are over an S. E. C. suspension, and who knows no more about it than you do, is someone who got caught by it. Sorry about that, but it serves you right.
"GVBP investors really value your input." I imagine a few would-be GVBP buyers valued it, which is more than you can say for your Harry Lime attitude toward others. There were no "investors" in GVBP, as you know. It wasn't an "investment". It was a scam, and anyone "playing" it was no better than the instigator of a chain letter scheme.
Now, Harry, that really is all. You can flood this board with your protests and call me "buddy" 100 times and profess how much money you made and how moral it is to use scams to try to filch money from other people, and I won't even see it. Have a nice life.
So this stock will trade as normal on Oct 7. We will see pps down but not as bad as some guy talk. PPs will be low but not less than .10!!!!! From that information from stockwatch...i assume pps will be ok. I feel a bite better after i read this information from stockwatch. We shall see.
BUDDY STOP sending me messages...
dont you get it
you posted 100+ messages in less than a month... when this stock was around .03 to .04
bashing this stock, or talking about how no one should invest in it...
yet in 7 days it went from .10 to 1.18
talk about a waste of time
even at its worse when people were finding out this was a pump and dump.... it closed still higher than when you started your bash, or information campaign, or what ever you call it
LOL (L)
that right keep typing
GVBP investors really value your input
wow where did every go" reminds me of that scummy apartment I had in Toronto - turn on the kitchen light all the cockroaches ran for cover
Neither Genova or its local director, Dirk Holzhauer, returned calls seeking comment on the halt. Mr. Holzhauer was the company's president prior to the July 13, 2009, name change, and he remains on the board. The company lists its president as Aaron Whiteman, a resident of Stockholm, Sweden.
Stockwatch also left an unreturned message for Daniel Baxter, a Surrey man listed in regulatory filings as having control over 43.7 per cent of the company's shares. Mr. Baxter is the president of Wall Street Transfer Inc., a transfer agent with its office in the small Vancouver suburb of Pitt Meadows, B.C. According to Genova's July 1, 2009, information circular, he controlled 1.15 million of the company's shares prior to the 125:1 split. Assuming this holding remained unchanged, he would have held 143 million of Genova's 307 million shares after the split.
According to the circular, Mr. Baxter controlled most of those shares through Global Developments Inc., the publicly traded company formerly headed by Vancouver securities lawyer John Briner. Mr. Baxter took over as president of Global Developments in 2007 after Mr. Briner resigned, citing bad press and comments in Internet forums. Global Developments, which invested in several pink sheets companies, received much negative attention after some of its investee companies became the targets of spam campaigns, as did Global Developments itself. The B.C. Securities Commission halted Global Developments on July 9, 2007, because of the spam. At the time, Mr. Baxter told Stockwatch that he had no idea who was behind the junk e-mails.
The SEC's halt of Genova will last for 10 business days, and will end on Oct. 6, 2009. Unlike halts in Canada, those issued by the SEC place an onerous burden on brokers even after the company resumes trading. They must keep up-to-date information on the company's financial status and on its insiders. They must also have a copy of the company's prospectus, its most recent annual report and any subsequent quarterly reports. In addition, brokers must maintain current information on the company's name, address, state of incorporation, number of shares outstanding, the name of its transfer agent and the nature of its products. Brokers must also know if a price quotation is from another broker or from an insider. This information, along with specific names, must be available to anyone interested in trading the company.
http://www.stockwatch.com/newsit/newsit_newsit.aspx?bid=U-s0129079-U:*SEC-20090925&symbol=*SEC&news_region=U
SEC halts cancer-cure company Genova
Ticker Symbol: C:*SEC U:*SEC
SEC halts cancer-cure company Genova
U.S. Securities and Exchange Commission (C:*SEC)
Friday September 25 2009 - Street Wire
Also U.S. Securities and Exchange Commission (U:*SEC) Street Wire
by Mike Caswell
The U.S. Securities and Exchange Commission has halted Genova Biotherapeutics Inc., a company that claims to have patents describing cures for prostate cancer and breast cancer. In a brief halt notice dated Sept. 23, 2009, the SEC cites questions about the accuracy of the company's publicly available information. "The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in Genova's securities," the notice reads.
Genova trades on the OTC Bulletin Board. During September, it went from a low of nine cents to a high of 79.5 cents, as it issued several news releases touting technology that purportedly used stem cells to fight cancer. The stock traded 467.3 million shares during the month.
The company is a very recent entrant to the biotechnology sector. Until this summer, it called itself Kinder Travel Inc. and listed its head office at an address in Surrey, B.C. It claimed to be in the business of specialty travel, catering to Christian families. In its most recent balance sheet, dated June 30, 2009, Kinder reported $28,000 in cash.
On July 13, 2009, Kinder split its shares 125:1 and changed its name to Genova. It began touting itself as a biotechnology company that would "achieve breakthroughs in anti-cancer treatments" and would license those products to larger companies. Genova's primary asset was an agreement to acquire three medical patents from Phoinos Oxford Lifesciences Ltd., a company incorporated in St. Kitts & Nevis. Genova agreed to pay $75,000 (U.S.) for the patents, to be satisfied by issuing 250,000 presplit shares.
In September, the stock started rising as the company issued a series of news releases touting the patents. One, dated Sept. 11, 2009, said the company would develop specially designed stem cells that would be able to overcome cancerous cells in breast cancer patients. "Development of this important biotechnology would mean a new cure for cancer, rendering disfiguring mastectomies and harmful radiation therapies obsolete," the news release read. The stock, which had traded at nine cents a week earlier, closed at 29 cents on volume of 73.9 million shares.
The next trading day, the company issued more news as the stock again rose on heavy volume. One stated that the company was awaiting preclinical results for Prostaganin, a product that was purportedly a candidate for treating prostate cancer. The stock went to 43 cents on volume of 61.0 million shares.
Genova reached its peak the next day, Sept. 15, when it reported that it had signed an agreement with a British company, Prime BioResearch Ltd., to help develop its products. Genova closed at 79.5 cents on volume of 58.7 million shares. The company did not issue any further news, and the stock started steadily declining after that. It had fallen to 18 cents by the time the SEC halted it on Sept. 23.
Neither Genova or its local director, Dirk Holzhauer, returned calls seeking comment on the halt. Mr. Holzhauer was the company's president prior to the July 13, 2009, name change, and he remains on the board. The company lists its president as Aaron Whiteman, a resident of Stockholm, Sweden.
Stockwatch also left an unreturned message for Daniel Baxter, a Surrey man listed in regulatory filings as having control over 43.7 per cent of the company's shares. Mr. Baxter is the president of Wall Street Transfer Inc., a transfer agent with its office in the small Vancouver suburb of Pitt Meadows, B.C. According to Genova's July 1, 2009, information circular, he controlled 1.15 million of the company's shares prior to the 125:1 split. Assuming this holding remained unchanged, he would have held 143 million of Genova's 307 million shares after the split.
According to the circular, Mr. Baxter controlled most of those shares through Global Developments Inc., the publicly traded company formerly headed by Vancouver securities lawyer John Briner. Mr. Baxter took over as president of Global Developments in 2007 after Mr. Briner resigned, citing bad press and comments in Internet forums. Global Developments, which invested in several pink sheets companies, received much negative attention after some of its investee companies became the targets of spam campaigns, as did Global Developments itself. The B.C. Securities Commission halted Global Developments on July 9, 2007, because of the spam. At the time, Mr. Baxter told Stockwatch that he had no idea who was behind the junk e-mails.
The SEC's halt of Genova will last for 10 business days, and will end on Oct. 6, 2009. Unlike halts in Canada, those issued by the SEC place an onerous burden on brokers even after the company resumes trading. They must keep up-to-date information on the company's financial status and on its insiders. They must also have a copy of the company's prospectus, its most recent annual report and any subsequent quarterly reports. In addition, brokers must maintain current information on the company's name, address, state of incorporation, number of shares outstanding, the name of its transfer agent and the nature of its products. Brokers must also know if a price quotation is from another broker or from an insider. This information, along with specific names, must be available to anyone interested in trading the company.
2009 Canjex Publishing Ltd.
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1341
|
Created
|
07/12/09
|
Type
|
Free
|
Moderators |
Genova Biotherapeutics, Inc. (GVBP)
Company Information:
1461 A. First Ave. #360
New York, NY 10021-2209
Phone: 646-845-1920
Fax: 646-514-7436
E-mail: investorrelations@genovabio.com
CIK: 0001364587
GENova is a biotechnological drug development company with a strict focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings.
Each and every product candidate targets problem areas with considerable unmet need and ditto market potential. Subsequent inexpensive value-addition benefits both patients and stakeholders.
Fully developed our efficient programmes are then transferred to larger organizations, these being either other biotech companies and/or Big Pharma with infrastructures large enough to bring the products to market in a big scale.
Management:
http://www.genovabio.com/management.html
GENova is fully committed to ensuring that the company can continue to operate and bring both new and exciting partners into the business and pursue the capital opportunities that the company was closing prior to the SEC investigation. Subsequently we are re-organizing the management team and corporate structure to better reflect legal, market and capital requirements.
GENOVA MANAGEMENT
NOTE TO SHAREHOLDERS!!!
Recent News: http://www.otcmarkets.com/pink/quote/quote.jsp?symbol=gvbp
OTC Disclosure & News Service | |||||||||
|
Filings:
Transfer Agent:
Action Stock Transfer
7069 Highland Drive
Suite 300
Salt Lake City, UT 84121
Share Structure:
coming
Investor Relations:
Windfall Communications LLC.
Brian Cook
Tel: +1 (866)797-8703
info@windfallcommunications.com
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |